Skip to main content
SpringerLink
Log in

Molecular genetic studies of cognitive deficit in schizophrenia

  • Devoted the Memory of Lev L’vovich Kisselev
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Cognitive deficit is a key feature of schizophrenia. Genetic factors are thought to contribute to cognitive disturbances in schizophrenic patients. However, the role of specific genes in the development of cognitive deficit remains elusive. The review considers the current studies on the association between gene polymorphisms and cognitive dysfunction in schizophrenics. Main attention is drawn to the consistently reproducible association between the COMT polymorphism Val158Met and cognitive traits, which has a biological and neuropsychological support. The association studies with the genes for the dopamine and serotonin receptors, brain-derived neurotrophic factor, dysbindin, DISC1, D-amino acid oxidase, and D-amino acid oxidase activator are reviewed as well.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marder S.R., Fenton W. 2004. Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr. Res. 72, 5–9.

    Article  PubMed  Google Scholar 

  2. Malhotra A.K., Kestler L.J., Mazzanti C., et al. 2002. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry. 159, 652–654.

    Article  PubMed  Google Scholar 

  3. Fossella J., Sommer T., Fan J., et al. 2002. Assessing the molecular genetics of attention networks. BMC Neurosci. 3, 14–21.

    Article  PubMed  Google Scholar 

  4. Goldberg T.E., Egan M.F., Gscheidle T., et al. 2003. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch. Gen. Psychiatry. 60, 889–896.

    Article  PubMed  CAS  Google Scholar 

  5. Bilder R.M., Volavka J., Czobor P., et al. 2002. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol. Psychiatry. 52, 701–707.

    Article  PubMed  CAS  Google Scholar 

  6. Bruder G.E., Keilp J.G., Xu H., et al. 2005. Catechol-O-methyltransferase (COMT) genotypes and working memory: Associations with differing cognitive operations. Biol. Psychiatry. 58, 901–907.

    Article  PubMed  CAS  Google Scholar 

  7. Bearden C.E., Jawad A.F., Lynch D.R., et al. 2004. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am. J. Psychiatry. 161, 1700–1702.

    Article  PubMed  Google Scholar 

  8. Barnett J.H., Jones P.B., Robbins T.W., Muller U. 2007. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: A meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol. Psychiatry. 12, 502–509.

    PubMed  CAS  Google Scholar 

  9. Diamond A., Briand L., Fossella J., Gehlbach L. 2004. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am. J. Psychiatry. 161, 125–132.

    Article  PubMed  Google Scholar 

  10. Alfimova M.V., Golimbet V.E., Gritsenko I.K., et al. 2006. Interaction of dopaminergic system genes and cognitive functions in patients with schizophrenia, their relatives, and healthy persons from general population. Zh. Nevrol. Psikhiatr. im. S.S. Korsakova. 106, 57–63.

    PubMed  CAS  Google Scholar 

  11. Bartres-Faz D., Junque C., Serra-Grabulosa J.M., et al. 2002. Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects. Neurorept. 13, 1121–1125.

    Article  CAS  Google Scholar 

  12. Rodriguez-Jimenez R., Hoenicka J., Jimenez-Arriero M.A., et al. 2006. Performance in the Wisconsin Card Sorting Test and the C957T polymorphism of the DRD2 gene in healthy volunteers. Neuropsychobiology. 54, 166–170.

    Article  PubMed  CAS  Google Scholar 

  13. Szekeres G., Keri S., Juhasz A., et al. 2004. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 124, 1–5.

    Article  Google Scholar 

  14. Lowe N., Kirley A., Hawi Z., et al. 2004. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am. J. Hum. Genet. 74, 348–356.

    Article  PubMed  CAS  Google Scholar 

  15. Golimber V.E., Alfimova M.V., Gritsenko I.K., et al. 2008. Association of dopamine receptor D5 gene polymorphism with specific features of voluntary attention in patients with schizophrenia and their relatives. Byull. Eksp. Biol. Med. 145, 71–73.

    Google Scholar 

  16. Chen R.Y., Sham P., Chen E.Y., et al. 2001. No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Res. 105, 175–185.

    Article  PubMed  CAS  Google Scholar 

  17. Golimbet V.E., Alfimova M.V., et al. 2006. Verbal memory deficit in schizophrenia as a possible endophenotype of the disease. In: Schizoaffective Disorder: New Research. Ed. Murray W.H. N.Y.: Nova Science Publ., 165–186.

    Google Scholar 

  18. Ucok A., Alpsan H., Cakir S., Saruhan-Direskeneli G. 2007. Association of a serotonin receptor 2A gene polymorphism with cognitive functions in patients with schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144, 704–707.

    Google Scholar 

  19. Reuter M., Ott U., Vaitl D., Hennig J. 2007. Impaired executive control is associated with a variation in the promoter region of the tryptophan hydroxylase 2 gene. J. Cogn. Neurosci. 19, 401–408.

    Article  PubMed  Google Scholar 

  20. Harris S.E., Fox H., Wright A.F., et al. 2006. The brainderived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol. Psychiatry. 11, 505–513.

    Article  PubMed  CAS  Google Scholar 

  21. Rybakowski J.K., Borkowska A., Skibinska M., et al. 2006. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin. Neurosci. 60, 70–76.

    Article  PubMed  CAS  Google Scholar 

  22. Ho B.C., Milev P., O’Leary D.S., et al. 2006. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch. Gen. Psychiatry. 63, 731–740.

    Article  PubMed  CAS  Google Scholar 

  23. Tsai S.J., Hong C.J., Yu Y.W., Chen T.J. 2004. Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology. 49, 13–16.

    Article  PubMed  CAS  Google Scholar 

  24. Alfimova M.V., Lezheiko T.V., Golimbet V.E., et al. 2008. Role of brain netrotrophic factor genetic polymorphism in processes of voluntary and involuntary attention and their pathology in schizophrenia. Zh. Nevrol. Psikhiatr. im. S.S. Korsakova. 107, 59–66.

    Google Scholar 

  25. Donohoe G., Morris D.W., Clarke S., et al. 2007. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia. 45, 454–458.

    Article  PubMed  Google Scholar 

  26. Stefanis N.C., Trikalinos T.A., Avramopoulos D., et al. 2007. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol. Psychiatry. 62, 784–792.

    Article  PubMed  CAS  Google Scholar 

  27. Hennah W., Tuulio-Henriksson A., Paunio T., et al. 2005. A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol. Psychiatry. 10, 1097–1103.

    Article  PubMed  CAS  Google Scholar 

  28. Thomson P.A., Harris S.E., Starr J.M., et al. 2005. Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci. Lett. 389, 41–45.

    Article  PubMed  CAS  Google Scholar 

  29. Egan M.F., Goldberg T.E., Kolachana B.S., et al. 2001. Effect of COMT Val108/158Met genotype on frontal lobe function and risk schizophrenia. Proc. Natl. Acad. Sci. USA. 98, 6917–6922.

    Article  PubMed  CAS  Google Scholar 

  30. Tsai S.J., Yu Y.W., Chen T.J., et al. 2003. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci. Lett. 338, 123–126.

    Article  PubMed  CAS  Google Scholar 

  31. Golimbet V.A., Gritsenko I.K., Alfimova M.V., et al. 2006-a. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J. Biol. Psychiatry. 7, 238–245.

    Article  PubMed  Google Scholar 

  32. Stip E. 2006. Cognition, schizophrenia and the effect of antipsychotics. Encephale. 32(1), 341–350.

    Article  PubMed  CAS  Google Scholar 

  33. Muir W.J., Thomson M.L., McKeon P., et al. 2001. Markers close to the dopamine D5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder. Am. J. Med. Genet. 105, 152–158.

    Article  PubMed  CAS  Google Scholar 

  34. Wingen M., Kuypers K.P., Ramaekers J.G. 2007. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: A mechanistic study in healthy volunteers. Psychopharmacology (Berlin). 190, 391–400.

    Article  CAS  Google Scholar 

  35. Hernandez I., Sokolov B.P. 2000. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment. J. Neurosci. Res. 59, 218–225.

    Article  PubMed  CAS  Google Scholar 

  36. Potkin S.G., Fleming K., Jin Y., Gulasekaram B. 2001. Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics. J. Clin. Psychopharmacol. 21, 479–483.

    Article  PubMed  CAS  Google Scholar 

  37. Alfimova M.V., Golimbet V.E., Mityushina N.G. 2003. Polymorphism of the serotonin receptor type 2A (5-HTR2A) gene and verbal fluency in normalcy and in schizophrenia. Mol. Biol. 37, 68–73.

    Article  CAS  Google Scholar 

  38. Polesskaya O., Sokolov B. 2002. Differential expression of the “C” and “T” alleles of the 5-HTR2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 67, 812–822.

    Article  PubMed  CAS  Google Scholar 

  39. Reuter M., Esslinger C., Montag C., et al. 2008. A functional variant of the tryptophan hydroxylase 2 gene impacts working memory: A genetic imaging study. Biol. Psychol. Jan 29.

  40. Egan M., Kojima M., Callicott J., et al. 2003. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 112, 257–269

    Article  PubMed  CAS  Google Scholar 

  41. Szeszko P.R., Lipsky R., Mentschel C., et al. 2005. Brain-derived neurotrophic factor Val66Met polymorphism and volume of the hippocampal formation. Mol. Psychiatry. 10, 631–636.

    Article  PubMed  CAS  Google Scholar 

  42. Funke B., Finn C.T., Plocik A.M., et al. 2004. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am. J. Hum. Genet. 75, 891–898.

    Article  PubMed  CAS  Google Scholar 

  43. Fallgatter A.J., Herrmann M.J., Hohoff C., et al. 2006. DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals. Neuropsychopharmacology. 31, 2002–2010.

    Article  PubMed  CAS  Google Scholar 

  44. Blackwood D.H., Glabus M.F., Dunan J., et al. 1999. Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia: Correlations with memory and P300. Br. J. Psychiatry. 175, 357–366.

    Article  PubMed  CAS  Google Scholar 

  45. James R., Adams R.R., Christie S., et al. 2004. Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol. Cell. Neurosci. 26, 112–122.

    Article  PubMed  CAS  Google Scholar 

  46. Millar J.K., Pickard B.S., Mackie S., et al. 2005. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science. 310, 1187–1191.

    Article  PubMed  CAS  Google Scholar 

  47. Goldberg T.E., Straub R.E., Callicott J.H., et al. 2006. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology. 31, 2022–2032.

    Article  PubMed  CAS  Google Scholar 

  48. Papiol S., Molina V., Rosa A., et al. 2007. Effect of interleukin-1beta gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144, 1090–1093.

    Google Scholar 

  49. Reuter M., Peters K., Schroeter K., et al. 2005. The influence of the dopaminergic system on cognitive functioning: A molecular genetic approach. Behav. Brain Res. 16, 93–99.

    Article  Google Scholar 

  50. Paunio T., Tuulio-Henriksson A., Hiekkalinna T., et al. 2004. Search for cognitive trait components of schizophrenia reveals a locus for verbal learning and memory on 4q and for visual working memory on 2q. Hum. Mol. Genet. 13, 1693–1702.

    Article  PubMed  CAS  Google Scholar 

  51. Apud J.A., Weinberger D.R. 2007. Treatment of cognitive deficits associated with schizophrenia: Potential role of catechol-O-methyltransferase inhibitors. CNS Drugs. 21, 535–557.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mental Health Research Center, Russian Academy of Medical Sciences, Moscow, 115552, Russia

    V. E. Golimbet

Authors
  1. V. E. Golimbet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. E. Golimbet.

Additional information

Original Russian Text © V.E. Golimbet, 2008, published in Molekulyarnaya Biologiya, 2008, Vol. 42, No. 5, pp. 830–839.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Golimbet, V.E. Molecular genetic studies of cognitive deficit in schizophrenia. Mol Biol 42, 738–746 (2008). https://doi.org/10.1134/S0026893308050117

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893308050117

Key words

Search

Navigation